The case for retaining borderline personality disorder as a psychiatric diagnosis by Paris, Joel et al.
Copyright © 2009 John Wiley & Sons, Ltd 3: 96–100 (2009)
DOI: 10.1002/pmh
Formal Rebuttal
The case for retaining borderline personality 
disorder as a psychiatric diagnosis
Personality and Mental Health
3: 96–100 (2009)
Published online in Wiley InterScience 
(www.interscience.wiley.com) DOI: 10.1002/pmh.73
JOEL PARIS1, KENNETH R. SILK2, JOHN GUNDERSON3, PAUL S. LINKS4 AND MARY 
ZANARINI3, 1McGill University, Montreal, Canada; 2University of Michigan Health System, Ann 
Arbor, MI, USA; 3McLean Hospital, Harvard University, Belmont, MA, USA; 4University of 
Toronto, Toronto, Canada
Introduction
The paper by Tyrer (2009) suggests that borderline 
personality disorder (BPD) is neither borderline 
nor a personality disorder. We agree—at least par-
tially. The term ‘borderline’ has historical signi-
fi cance, but does not describe any meaningful 
border, and BPD differs from most personality 
disorders in being associated with a wide range of 
disabling symptoms (Paris, 2007, 2008a). However, 
it does not follow that BPD should be reclassifi ed 
as a mood disorder or that it should be eliminated 
from the diagnostic system.
Why BPD is not a mood disorder
Affective instability (AI), or emotional dysregula-
tion (or, to use the term suggested by Tyrer, ‘fl uxi-
thymia’), describes short-term mood swings in 
which affect is intense and returns only slowly to 
normal levels (Harvey, Greenberg, & Serper, 1989; 
Herpertz et al., 1997). The idea that AI is an 
essential feature of BPD has been suggested before 
(Akiskal, Chen, & Davis, 1985; Linehan, 1993; 
Livesley, Jang, & Vernon, 1998) and has been sup-
ported by research (Henry et al., 2001; Koenigsberg 
et al., 2002). This clinical phenomenon has stimu-
lated a large body of research (Putnam & Silk, 
2005). However, it does not follow that AI explains 
all the symptoms in BPD patients or that it should 
be placed in the same category as classical mania 
and depression.
BPD is a complex and multidimensional syn-
drome whose symptoms are not confi ned to or 
accounted for by changes in mood (Paris, 2007). 
Several lines of evidence contradict this hypothe-
sis that the symptoms of BPD can be accounted 
for by changes in mood. First, AI differs from clas-
sical depression in being a short-lived and exagger-
ated response to interpersonal stressors (Gunderson 
& Phillips, 1991; Russell, Moskowitz, Zuroff, 
Sookman, & Paris, 2007) rather than being cha-
racterized by sustained lowered mood. Moreover, 
AI responds inconsistently, if at all, to antidepre-
ssant treatment (Paris, 2008a). For example, as 
we know from the Collaborative Longitudinal 
Personality Disorders Study, in only 20% of the 
BPD cases with comorbid major depressive disor-
der (MDD) did the depression remit after treat-
ment with antidepressants. Even when the 
depression did remit, its remission had little effect 
on the course of BPD. In contrast, when the BPD 
remitted, this remission was followed by improve-
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ments in the severity of the MDD (Gunderson 
et al., 2004).
Second, AI does not make BPD a bipolar spec-
trum disorder. Although there is some comorbidity 
with bipolar-II, most cases are distinct, and these 
disorders do not overlap when patients are 
followed over time (Gunderson et al., 2006; Paris, 
Gunderson, & Weinberg, 2007). BPD patients 
also respond inconsistently to treatment with 
mood stabilizers (Paris, 2008a), and most of the 
impact of mood stabilizers is limited to symptoms 
of anger/impulsivity (Mercer, Douglass, & Links, 
2009).
Third, impulsivity is just as central to BPD as 
AI. Impulsivity is a core feature without which the 
diagnosis would rarely even be considered (Links, 
Heselgrave, & van Reekum, 1999). It is diffi cult to 
see how mood instability by itself can account for 
recurrent suicide attempts, self-harm, substance 
abuse, eating disorders, sexual promiscuity or 
antisocial behaviours. Impulsive behaviours often 
function to regulate dysphoria.
Patients with BPD score high on all dimensions 
of impulsivity (Links et al., 1999; Paris et al., 2004). 
Impulsive spectrum disorders (such as antisocial 
personality and substance abuse) are the most fre-
quent disorders in the fi rst-degree relatives of BPD 
probands, and are more common than mood dis-
orders (Silverman et al., 1991; White, Gunderson, 
Zanarini, & Hudson, 2003). Moreover, high levels 
of impulsivity are the most consistent predictor of 
clinical outcome in BPD (Links et al., 1999). 
Finally, neurobiological studies show that impul-
sivity in BPD is the only trait that has a robust 
association with biological markers. This has been 
shown by abnormalities in neurotransmitter activ-
ity in challenge tests (Coccaro et al., 1989; Paris 
et al., 2004), and in neuroimaging (Leyton et al., 
2001; Siever et al., 1999).
Fourth, problems in interpersonal relationships 
are equally characteristic of BPD. One sees a 
pattern of interpersonal hypersensitivity, often 
associated with disorganized or ambivalent attach-
ment styles, intolerance of aloneness, abandon-
ment fears and a self-image of being evil (Gunderson, 
1984; Gunderson & Lyons-Ruth, 2008; Zanarini 
& Frankenburg, 1994). Again, these complex 
phenomena are not easily accounted for by mood 
alone, and in fact are thought of as very atypical 
or exceptional if they were found in mood disor-
ders. The depression in BPD is frequently marked 
by loneliness and emptiness (Westen et al., 1992), 
and while major depression per se is usually not 
responsive to environmental factors, the depres-
sion in BPD is often acutely responsive to environ-
mental (i.e. interpersonal) factors.
Fifth, BPD patients often have prominent 
cognitive symptoms (Zanarini, Gunderson, & 
Frankenburg, 1990). Chronic depersonalization, 
paranoid trends, and transient delusions and hal-
lucinations are all commonly present, and these 
symptoms are not often seen in patients with 
non-psychotic mood disorders.
These observations have important clinical 
implications. Defi ning BPD as a mood disorder 
might suggest that these are patients who should 
be given pharmacological treatment for AI. 
However, there is no evidence from randomized 
clinical trials that these agents are particularly 
effective in BPD (Paris, 2008a). While antidepres-
sants and mood stabilizing drugs show some thera-
peutic effects (primarily on impulsivity), they do 
not stabilize the unstable mood of BPD, and never 
produce remissions.
The essence of the BPD diagnosis is that it 
describes multiple domains of pathology, rooted in 
multiple diatheses and endophenotypes. This con-
clusion has been supported by cluster analyses of 
BPD symptoms (Hurt, Clarkin, Munroe-Blum, & 
Marziali, 1992; Sanislow et al., 2002), which have 
found that emotional dysregulation, impulsivity 
and disturbed relationships form partially separate 
domains. Each of these clusters could be associated 
with specifi c neurobiological mechanisms (Paris, 
2008b; Siever & Davis, 1991; Silk, 2000; Skodol 
et al., 2002). While it is tempting to simplify a 
complex problem, reducing BPD to mood instabil-
ity does not do it justice.
To dismiss the concept of BPD because it may 
describe multiple domains of pathology, rooted 
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in multiple diatheses and endophenotypes, seems 
quite selective because there are many psychiatric 
disorders that might involve multiple domains of 
pathology and rooted in multiple endophenotypes 
and diatheses. Post-traumatic stress disorder as well 
as schizophrenia could serve as examples of this 
‘multiplicity’, but no one is suggesting that these 
diagnoses be eliminated. Further, we appreciate 
that schizophrenia is far from a disorder wherein 
the personality is split, the original concept of 
schizophrenia and upon which the name schizo-
phrenia was devised.
The importance of the BPD diagnosis 
for treatment
A main purpose of any psychiatric classifi cation 
is to provide a guide to treatment. That is the 
most important reason for retaining the BPD 
diagnosis.
In recent years, a large and important recent 
literature has emerged, demonstrating the effi cacy 
of specifi c psychotherapies designed for the BPD 
patient population (e.g. Bateman & Fonagy, 2006; 
Clarkin, Levy, Lenzenweger, & Kernberg, 2007; 
Davidson et al., 2006; Giesen-Bloo et al., 2006; 
Linehan, 1993), though we cannot suggest that 
these treatments would be ineffective in other dis-
orders. What is most striking about these fi ndings 
is that standard psychological treatments (usually 
called ‘treatment as usual’) are not very effective 
in BPD, while therapies designed for this diagnos-
tic category are much superior. In addition, recent 
empirical work has explicated the mechanisms of 
action of the therapies such as transference-focused 
psychotherapy and does not support the resolution 
of unstable mood as central to the changes related 
to the therapy (Levy et al., 2006). Given these 
advances, making a diagnosis of BPD makes a 
difference in practice because clinicians need to 
conduct treatment differently.
For these reasons, we are concerned that remov-
ing BPD from the classifi cation will rebound nega-
tively on patients. This population will not go 
away; however, the diagnosis is redefi ned. Because 
BPD patients are clinically problematic, they have 
often been inadequately managed: in earlier times, 
by offering classical forms of psychotherapy that 
are not appropriate for them, and more recently, 
by offering polypharmacy regimes that are not 
appropriate (Zanarini, Frankenburg, Khera, & 
Bleichmar, 2001).
Future directions
While we recommend the retention of BPD in the 
Diagnostic and Statistical Manual of Mental 
Disorders (DSM)-V, we do not favour the retention 
of the current criteria, which badly need revision. 
Diagnostic algorithms need to be more specifi c as 
opposed to the current ‘Chinese menu approach’ 
in which any fi ve out of nine unweighted criteria 
is considered suffi cient. The introduction of symp-
toms, such as a high degree of subjective emotional 
pain, which have been found to be both common 
among and specifi c to BPD, should be considered 
for inclusion in DSM-V (Zanarini & Frankenburg, 
1994; Zittel Conklin & Westen, 2005). In addition, 
the introduction of some kind of dimensional 
scoring might help (Krueger, Skodol, Livesley, 
Shrout, & Huang, 2007), although empirical evi-
dence is needed to prove that such a procedure 
would actually increase validity. And diagnostic 
reform needs to be applied to all categories of 
disorders in DSM-V, not just BPD.
Finally, we agree that ‘borderline personality’ is 
a bad name. Much bias and stigma are attached to 
the name but there is no evidence that changing 
the name will prevent the stigma from migrating 
to the new diagnosis. Schizophrenia or cancer 
were diagnoses that, a few generations ago, were 
an anathema to utter. But the names were not 
eliminated; rather, the public was educated as to 
what these diseases or disorders really were. And 
now we have schizophrenia centres and cancer 
centres of excellence. So before we replace one 
diagnostic name with another, we need further 
understanding of the disorder. We are far from this 
goal for almost all categories in the DSM system. 
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To rename BPD as ‘emotional regulation disorder’ 
or ‘fl uxithymia’ assumes that we understand psy-
chopathology, when in fact we do not, and also 
assumes that the new name will provide better 
care for these patients. The most conservative 
position when aetiology and pathogenesis are 
unknown is to continue conducting research until 
we have solid fi ndings on which to base a new 
classifi cation.
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